Financial Quality Control of In-Patient Chemotherapy in Germany: Are Additional Payments Cost-Covering for Pharmaco-Oncological Expenses? mydrg.de

scatter_plot

Financial Quality Control of In-Patient Chemotherapy in Germany: Are Additional Payments Cost-Covering for Pharmaco-Oncological Expenses?

• B.S.
• Donnerstag, 12.05.2011

Financial Quality Control of In-Patient Chemotherapy in Germany: Are Additional Payments Cost-Covering for Pharmaco-Oncological Expenses? (Karger).

Arzneimittel - Begleitforschung - Chemotherapie - Deckungsbeitrag - Dokumentation - DRG - Fallpauschalen - Kostenvergleich - Onkologie - Zusatzentgelte - URL

« "Die Tage werden intensiver für alle, die mit Patienten arbeiten" | Financial Quality Control of In-Patient Chemotherapy in Germany: Are Additional Payments Cost-Covering for Pharmaco-Oncological Expenses? | Hamburg: Weitere 250 LBK-Rückkehrer »